Whalegun
Home

David Kirn, CEO: 4D Molecular Therapeutics FDMT Sell · Filed 24/01/25

Trade details

Type
Insider sale
Amount
$104,863.36
Shares · price
5,696 sh · $18.41 a share
Held after
1,151,154 sh
Stock
4D Molecular Therapeutics FDMT
Person
David KirnCEO
Trade date
24/01/23
Filed
24/01/25
Days to filing
2 days

Sold 0.5% of holdings

Share of holding sold
0.5%

4D Molecular Therapeutics trades, last 26 weeks

What else happened in 4D Molecular Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/24~24/02/22

David Kirn's recent trades

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $802.7K

    Filed 09/14

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $1.2M

    Filed 08/19

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $275.4K

    Filed 08/04

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $125.3K

    Filed 08/03

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $193.6K

    Filed 07/10